Solid organ transplant and the risk of cancer

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1378, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management

By Tessari Gianpaolo   Girolomoni Giampiero  

Dermatologic Surgery, Vol. 38, Iss. 10, 2012-10 ,pp. : 1622-1630

Elsevier

Access to resources Recommend Favorite

Valganciclovir: therapeutic role in pediatric solid organ transplant recipients

By Yu Marie A   Park Jeong M  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 807-815

Informa Healthcare

Access to resources Recommend Favorite

Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

By Åsberg Anders   Rollag Halvor   Hartmann Anders  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1159-1166

Informa Healthcare

Access to resources Recommend Favorite

Update on EBV monitoring, detection and therapy in PTLD after solid organ transplant

By Nowalk Andrew J   Green Michael  

Future Virology, Vol. 5, Iss. 3, 2010-05 ,pp. : 287-296

Future Medicine

Access to resources Recommend Favorite

Capecitabine to Reduce Nonmelanoma Skin Carcinoma Burden in Solid Organ Transplant Recipients

By Endrizzi Bart   Ahmed Rehana L.   Ray Theresa   Dudek Arkadiusz   Lee Peter  

Dermatologic Surgery, Vol. 39, Iss. 4, 2013-04 ,pp. : 634-645

Elsevier

Access to resources Recommend Favorite